Selective alterations in rat cardiac mRNA induced by doxorubicin: Possible subcellular mechanisms
- 1 April 1991
- journal article
- Published by Elsevier in Experimental and Molecular Pathology
- Vol. 54 (2) , 112-121
- https://doi.org/10.1016/0014-4800(91)90024-r
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- The interaction of the cardioprotective agent ICRF-187 ((+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane); its hydrolysis product (ICRF-198); and other chelating agents with the Fe(III) and Cu(II) complexes of adriamycinInflammation Research, 1989
- Amelioration of chronic anthracycline cardiotoxicity by ICRF-187 and other compoundsCancer Treatment Reviews, 1987
- Comparative effects of adriamycin and DNA-non-binding analogues on DNA, RNA, and protein synthesis in vitroCancer Chemotherapy and Pharmacology, 1987
- Effect of adriamycin on electron transport in rat heart, liver, and tumor mitochondriaExperimental and Molecular Pathology, 1987
- Prevention of doxorubicin-induced killing of MCF-7 human breast cancer cells by oxygen radical scavengers and iron chelating agentsBiochemical and Biophysical Research Communications, 1986
- alpha-skeletal and alpha-cardiac actin genes are coexpressed in adult human skeletal muscle and heart.Molecular and Cellular Biology, 1983
- Mechanism of RNA polymerase II-specific initiation of transcription in vitro: ATP requirement and uncapped runoff transcriptsCell, 1982
- Cloning of mouse mitochondrial DNA in E. coli affects bacterial viabilityGene, 1980
- Effects of anticancer agents on the respiration of isolated mitochondria and tumor cellsPublished by Elsevier ,1974
- Cumulative Cytostatic Effect of ICRF 159Nature, 1974